Determinants of Baseline Lung Allograft Dysfunction and its Long-term Impact on Pulmonary Function After Bilateral Lung Transplantation
Eva Revilla-Lopez, Paula Barquero-Dueñas, Arianna Andrade-Bustamante, Sara Salvador-Fernandez, Manuel Lopez-Meseguer, Alvaro Cantero-Acedo, Cristina Alexandra Romero-Espinosa, Marcos Arbiol-Urquizu, Luis Daniel Soto-Fernandez, Victor Monforte, Ana Villar, Susana Gómez-Ollés, Robin Vos, Cristina Berastegui, Berta Sáez-GiménezBackground.
Lung transplantation (LT) is the definitive treatment for selected end-stage lung diseases, yet some recipients fail to achieve normal pulmonary function posttransplant, a condition known as baseline lung allograft dysfunction (BLAD). Its causes and long-term outcomes remain incompletely understood.
Methods.
We retrospectively analyzed all adult bilateral LT performed between 2014 and 2019, with follow-up through December 2024. BLAD was defined as failure to achieve forced expiratory volume in 1 s and/or forced vital capacity ≥80% predicted within the first post-LT year. Multivariable logistic regression identified risk factors, and Cox and linear mixed-effects models assessed associations with survival, chronic lung allograft dysfunction (CLAD), and lung function trajectories.
Results.
Among 325 recipients, BLAD occurred in 65.5% and was independently associated with reduced survival (hazard ratio, 5.25; 95% confidence interval, 3.84-7.18;
Conclusions.
BLAD is common after LT and is associated with increased mortality and lower long-term pulmonary function. The BLAD-CLAD association may be partly confounded by structural or mechanical causes of reduced spirometry, supporting BLAD as a heterogeneous early post-LT phenotype.